Annual Report

Overview

The report presents FY2014 net sales of ¥1,161,152 million, operating income of ¥51,543 million, and net income of ¥30,891 million. It also highlights the acquisition of Medreich to expand pharmaceutical manufacturing and generic-drug sales in India, Asia, and Africa. Its CSR section focuses on personnel and the global environment, including a material balance and initiatives supporting women in the workplace.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2014-2015
Period: 1 April 2014 – 31 March 2015
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services